JPMorgan Future Transition Multi-Asset Fund
1. The Fund invests primarily (i.e. at least 70% of its total net asset value) in debt and equity securities (directly or indirectly through collective investment schemes) whose issuers may benefit from, or contribute to, the transition towards the future world. The Fund will have limited Renminbi (RMB) denominated underlying investments.
2. The Fund is therefore exposed to a range of investment related risks which includes risks associated with the Fund’s investment strategy (including risks associated with future transition concept, its sub-themes and changing market trends, risks associated with concentration in a single theme and/or sub-theme and risks associated with the use of big data and artificial intelligence technique), dynamic asset allocation strategy, debt securities (including downgrading risk, below investment grade/ unrated investment risk, credit risk, interest rate risk, valuation risk, volatility and liquidity risk), equity, emerging markets, investing in other collective investment schemes, concentration, currency, derivatives, liquidity, hedging, class currency and currency hedged classes. In addition, RMB hedged classes expose to risks associated with the RMB currency and currency hedged classes risks. RMB is currently not freely convertible and RMB convertibility from offshore RMB (CNH) to onshore RMB (CNY) is a managed currency process subject to foreign exchange control policies of and restrictions imposed by the Chinese government. There can be no assurance that RMB will not be subject to devaluation at some point. The Manager may, under extreme market conditions when there is not sufficient RMB for currency conversion and with the approval of the Trustee, pay redemption monies and/or distributions in USD.
3. Where the income generated by the Fund is insufficient to pay a distribution as the Fund declares, the Manager may at its discretion determine such distributions may be paid from capital including realised and unrealised capital gains. Investors should note that the payment of distributions out of capital represents a return or withdrawal of part of the amount they originally invested or from any capital gains attributable to that original investment. Any payments of distributions by the Fund may result in an immediate decrease in the net asset value per unit. Also, a positive distribution yield does not imply a positive return on the total investment. The distribution amount and net asset value per unit of a currency hedged class may be adversely affected by differences in the interest rates of the reference currency of the relevant currency hedged class and the Fund’s base currency, resulting in an increase in the amount of distribution that is paid out of capital and hence a greater erosion of capital than other classes of units.
4. Investors may be subject to substantial losses.
5. Investors should not solely rely on this document to make any investment decision.
#MedTech #FutureTrends #MultiAssetFund
Medical technology (medtech) in the future world
We are seeing rapid digital transformation and the application of advanced technologies in the healthcare industry. With rising life expectancy and living costs as well as more specialised medical care, the demand for cost-effective and innovative solutions is on the rise, presenting new investment opportunities.
Innovative medical care
Technology is advancing the process of diagnosis – listening & observing the signs and symptoms, enquiring about patient medical history and examining – while presenting market opportunities.
Observing Medical devices that employ facial recognition technology, artificial intelligence (AI) and machine learning can improve the accuracy of diagnosis.
Enquiring Smart data is also advancing the management and analysis of patients’ medical records, shortening consultation time and improving the efficiency of treatment.
Listening New communication technologies are enabling virtual conversations between patients and doctors. Such consultations could cost 3 times1 less than in-person visits.
Examining Wearable technology in healthcare is helping patients keep track of their heart rate and physical activity, and enabling doctors to better examine and assess their patients’ vital signs.
Advanced medical technologies are enhancing the quality of patient care while improving the efficiency and sustainability of healthcare systems, offering early-stage investment opportunities.
Unleashing opportunities in healthcare with a medtech blueprint
Optimising future world trends, the JPMorgan Future Transition Multi-Asset Fund helps investors capture long-term investment opportunities, focusing on the following themes2:
- Long-term development trend: digital technology’s value to healthcare systems is expected to reach US$3 trillion in 20302,3.
- Key potential markets2: medicial devices, in-vitro diagnostics, as well as information and communication technologies are key medtech categories that are presenting growth potential. These include wearable devices and AI innovations that are paving the way for automated surgeries.
Why invest in the JPMorgan Future Transition Multi-Asset Fund?
The Fund optimises five key future transition trends, seeking long-term growth opportunities via equity allocations while managing portfolio risk4 via a wide range of fixed income instruments.
The Fund’s exposure to relevant investment themes5